Foxconn has led the round through its European investment arm Ginko Ventures, while the corporate also invested directly alongside a consortium that included Renault and Sharp.

The biopharmaceutical developer, a spinout from medical device company Q-Med, is entering the third phase of testing a drug to prevent kidney failure.

BMW iVentures is establishing a $530m fund as it moves its headquarters from New York to Palo Alto to be closer to potential investees and drive an international expansion.

Chiesi Farmaceutici has agreed to acquire Atopix Therapeutics, an indirect spinout of Oxford University, in a transaction potentially worth in excess of $80m.

Chiesi Farmaceutici has agreed to acquire Atopix Therapeutics, an indirect spinout of Oxford University, in a transaction potentially worth in excess of $80m.

The newly formed Sodexo Ventures joined existing backer Orange Digital Ventures to help the point-of-sale software developer expand internationally.

The monoclonal antibody developer took its total funding to about $220m since 2010 in a round that included Shenzhen Hepalink and Malin Corporation.